Rocuronium Bromide

Brand (proprietary) name

None — marketed under its generic name

Generic (nonproprietary) name

Rocuronium Bromide

Active ingredient(s)

rocuronium bromide

Strength(s)

10 mg/mL; 100 mg/10mL; 50 mg/5mL

Dosage form(s)

Injection; Injection, Solution; Solution

Route(s)

Intravenous

Manufacturer / labeler

Hikma Pharmaceuticals USA Inc.B. Braun Medical Inc.Hospira, Inc.Sandoz IncSagent PharmaceuticalsXGen Pharmaceuticals DJB, Inc.Shandong New Time Pharmaceutical Co., Ltd.Baxter Healthcare CorporationSolco Healthcare US, LLCHF Acquisition Co LLC, DBA HealthFirstEugia US LLCCaplin Steriles LimitedMylan Institutional LLCGland Pharma LimitedLifestar Pharma LLCMeitheal Pharmaceuticals Inc.BE Pharmaceuticals Inc.Medical Purchasing Solutions, LLCCivica, Inc.STERISCIENCE SPECIALTIES PRIVATE LIMITEDProPharma Distribution

Product class

Generic (ANDA) (derived from FDA marketing category)

Marketing category

ANDA; NDA

Application number(s)

ANDA078519, ANDA079195, ANDA079199, ANDA091115, ANDA204679, ANDA205656, ANDA206206, ANDA212668, ANDA213453, ANDA215684, ANDA216234, ANDA217092, ANDA219260, ANDA219674, NDA219108

Earliest marketing start

Dec 1, 2008

Products / packages indexed

57 / 65

FDA pharmacologic class: Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Also searchable as: Rocuronium Bromide

Prescribing information on DailyMed (NLM)

No CMS NDC–HCPCS crosswalk row links this drug’s NDCs to a HCPCS code. That does not mean no code applies — CMS crosswalks are not comprehensive. Check the payer’s instructions; a not-otherwise-classified code may apply.

No authoritative public data was located for this field.

No authoritative public data was located for this field.

Home infusion per diem (S-codes)

Medicare

Not payable by Medicare — CMS coverage code I (all 2 codes)

Part B pricing indicator

00 — Not separately priced by Part B (all 2 codes)

National payment amount

No authoritative public data was located for this field.

Which Medicare benefit pays for this drug?

• Coverage documents for rocuronium bromide NCDs, LCDs, and Billing & Coding articles in the CMS Medicare Coverage Database that mention “rocuronium bromide”. Covered diagnosis codes are listed in the articles.
• Self-administered drug (SAD) exclusion lists Drugs each MAC excludes from “incident to” Part B coverage because they are usually self-administered.

No current Medicare Billing and Coding article lists this drug's codes.

No authoritative public data was located for this field.

• FDA NDC Directory data is submitted by labelers; FDA notes that inclusion does not mean the information was verified or that a product is approved, covered, or reimbursable.
• HCPCS links are derived from CMS NDC–HCPCS crosswalks, which support ASP-based Part B payment and are not a complete list of billable NDCs.
• Product class (brand, generic, biosimilar) is derived from the FDA marketing category and Purple Book license type, not from a commercial compendium.
• Payment limits are Medicare Part B national limits; they do not reflect payer contracts, OPPS rates, 340B pricing, or acquisition cost.
• Home infusion per diem S-codes are matched by therapy category from the FDA pharmacologic class and route, not from a CMS crosswalk. Payers choose which per diem codes they accept, and the right code can depend on the dosing schedule, infusion method, or daily volume.